Outcome of Intensively Treated Elderly AML Patients Reported to the Harmony Alliance Compares Well to Outcome of Control Patients of the Prospective Randomized HOVON 103 Study in Elderly AML
Sjoerd J. F. Hermans(University Medical Center), Jan J. Cornelissen(Erasmus MC), Eric Sträng(Humboldt-Universität zu Berlin), Jeroen J. W. M. Janssen(Radboud University Nijmegen), Klaus H. Metzeler(University Hospital Leipzig), Jurjen Versluis(Erasmus MC), Gerwin Huls(University Medical Center Groningen), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Jesús María Hernández‐Rivas(Universidad de Salamanca), Marta Sobas, Carin A. Uyl‐de Groot(Erasmus University Rotterdam), Lars Bullinger(Stanford University), Torsten Haferlach(Martin Luther Christian University), Thomas Pabst(University Hospital of Bern), Yvette van Norden(Erasmus MC Cancer Institute), Bob Löwenberg(Unknown), Erik van Werkhoven(The Netherlands Cancer Institute), Dimitri Breems(Ziekenhuisnetwerk Antwerpen Stuivenberg), Avinash G. Dinmohamed(Netherlands Comprehensive Cancer Organisation), Rosa Ayala(Hospital Universitario 12 De Octubre), Hartmut Döhner(University Hospital Ulm), Elizabeth Berkx(Netherlands Comprehensive Cancer Organisation), Gert J. Ossenkoppele(Dutch Cancer Society), Christian Thiede(University Hospital Carl Gustav Carus), Peter C. Huijgens(Netherlands Comprehensive Cancer Organisation), Francesco Pignatti
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k